Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FURBERG CD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 171 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fitzpatrick, AL; Daling, JR; Furberg, CD; Kronmal, RA; Weissfeld, JL
      Hypertension, heart rate, use of antihypertensives, and incident prostate cancer

      ANNALS OF EPIDEMIOLOGY
    2. Balkrishnan, R; Furberg, CD
      Developing an optimal approach to global drug safety

      JOURNAL OF INTERNAL MEDICINE
    3. Shlipak, MG; Simon, JA; Grady, D; Lin, F; Wenger, NK; Furberg, CD
      Renal insufficiency and cardiovascular events in postmenopausal women withcoronary heart disease

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    4. Furberg, CD; Pitt, B
      Are all angiotensin-converting enzyme inhibitors interchangeable?

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    5. Sinzinger, H; Lupattelli, G; Chehne, F; Oguogho, A; Furberg, CD
      Isoprostane 8-epi-PGF(2 alpha) is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    6. Pressel, SL; Davis, BR; Wright, JT; Geraci, TS; Kingry, C; Ford, CE; Piller, LB; Bettencourt, J; Kimmel, B; Lusk, C; Parks, H; Simpson, LM; Nwachuku, C; Furberg, CD
      Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

      CONTROLLED CLINICAL TRIALS
    7. Pahor, M; Psaty, BM; Alderman, MH; Furberg, CD
      Meta-analysis of hypertension trials in diabetic patients - Response to Paving and Rossing

      DIABETES CARE
    8. Pahor, M; Psaty, BM; Alderman, MH; Applegate, WB; Furberg, CD
      Blood-pressure-lowering treatment

      LANCET
    9. Goldstein, LB; Adams, R; Becker, K; Furberg, CD; Gorelick, PB; Hademenos, G; Hill, M; Howard, G; Howard, VJ; Jacobs, B; Levine, SR; Mosca, L; Sacco, RL; Sherman, DG; Wolf, PA; del Zoppo, GJ
      Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association

      STROKE
    10. Longstreth, WT; Bernick, C; Fitzpatrick, A; Cushman, M; Knepper, L; Lima, J; Furberg, CD
      Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study

      NEUROLOGY
    11. Pitt, B; Byington, RP; Furberg, CD; Miller, ME; Riley, W; Hunninghake, DB; Mancini, GBJ
      Does amlodipine increase cancer incidence? Response

      CIRCULATION
    12. Pitt, B; Byington, RP; Furberg, CD; Hunninghake, DB; Mancini, GBJ; Miller, ME; Riley, W
      Confusing press releases and the PREVENT study - Response

      CIRCULATION
    13. Ferrucci, L; Furberg, CD; Penninx, BWJH; Di Bari, M; Williamson, JD; Guralnik, JM; Chen, JG; Applegate, WB; Pahor, M
      Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile

      CIRCULATION
    14. Goldstein, LB; Adams, R; Becker, K; Furberg, CD; Gorelick, PB; Hademenos, G; Hill, M; Howard, G; Howard, VJ; Jacobs, B; Levine, SR; Mosca, L; Sacco, RL; Sherman, DG; Wolf, PA; del Zoppo, GJ
      Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association

      CIRCULATION
    15. Blackwell, B; Ederer, F; Van Veldhuisen, PC; Sullivan, EK; Dally, LG; Weber, PA; Miller, E; Katz, LJ; Ashburn, F; Beck, A; Costarides, A; Leef, D; Closek, J; Banks, J; Jackson, S; Moore, K; Vela, A; Brown, RH; Lynch, M; Gunsby, J; Lober, K; Marsh, T; Stepka, C; Montgomery, R; Clagett, D; Ashburn, F; Schacht, K; Coyle, E; Garland, MK; Lauber, S; Michelitsch, K; Plavnieks, S; Vayer, L; Burt, E; Hundley, M; Rae, A; Allen, RC; Miller, E; Sporn, A; Fendley, CK; Hoyle, LS; Weber, PA; McKinney, K; Moore, D; Lauderbaugh, T; Baker, ND; Kapetansky, F; Lehmann, D; Black, L; Derick, R; Gloeckner, B; Coleman, K; Cassady, M; Sharf, LJ; Romans, B; Satterwhite, Y; Simmons, L; Vela, MA; Harbin, TS; Brannon, L; LaSalle, J; Degenhardt, G; Bridgman, SA; Ozment, RR; Gunsby, J; Hooper, M; Wright, J; Goldstein, S; Butler, L; Perry, M; Eckel, A; Martin, A; Nummerdor, D; Wille, L; Cyrlin, MN; Dubay, H; Fazio, R; Corbin, PS; Wilensky, JT; Lindenmuth, K; Hillman, D; Carroll, CA; Hatton, J; Sonty, S; Carroll, CA; Higginbotham, EJ; Scholes, G; Uva, R; Fiene, J; Frohlichstein, D; Gates, V; Pappas, L; Rathbone, D; Tadelman, M; Hopkins, G; Lichter, PR; Bergstrom, TJ; Moroi, SE; Pollack-Rundle, CJ; Standardi, C; Abt, L; Van Heck, T; Skuta, GL; Higginbotham, EJ; Schertzer, RM; Wicker, D; Michael, B; Aaron, D; Birk, J; Brown, RS; Dederian, J; Kruscke, L; Ziehm-Scott, J; Papierniak-Dubiel, R; Prum, BE; Newman, SA; Powell, L; Evans, C; Barbour, N; Shoffstall-Tyler, L; Voight, T; Nordlund, JR; Schott, LJ; Fornili, R; Chisholm, J; Harrell, C; Harris, C; Murphy, E; Schwartz, AL; Weiss, H; Boeckl, A; Tillman, C; Boeckl, A; Maloney, L; Cirone, M; Gurley, J; Morris, M; O'Dea, M; Pappas, S; Wehrly, S; Reed, C; Witol, CV; Browning, J; Carmody, K; Driskell, T; Harris, E; Lopez, P; Mercer, R; Monks, V; Vawter, K; Zhao, J; Katz, LJ; Spaeth, GL; Wilson, RP; Myers, J; Samuel, F; Meli, A; Kao, S; Terebuh, A; Beckershoff, CC; Shields, MB; Shafranov, G; Leone, A; Grottole, G; Miller, E; Caprioli, J; Tressler, C; Roche-Manna, M; VanVeldhuisen, PC; Ederer, F; Dally, LG; Blackwell, B; Inman, P; Raitt, S; Lindblad, AS; Knoke, JD; Sullivan, EK; Wu, LL; Entler, G; Phillips, P; Smith, C; Bradford, M; Denekas, M; Wagner, EL; Stine, E; Tomlin, KL; Voss, T; Furberg, CD; Connett, JE; Davis, MD; Dueker, DK; Green, SB; Palmberg, PF; Ederer, F; Gaasterland, DE; Cotch, MF; Leikin, S; Schneiderman, M; Hamilton, MP; Mowery, RL; VanVeldhuisen, PC; Schwartz, AL; Lindblad, AS; Knoke, JD; Sullivan, EK; Schwartz, AL; Kassoff, A; Cotch, MF; Cyrlin, MN; Vela, MA; Caprioli, J; Higginbotham, EJ; Skuta, GL; Katz, LJ; Weber, PA; Allen, RC; Wilensky, JT; Miller, E; Brown, R; Prum, B; Cyrlin, M; Beck, A; Lichter, P; Leef, D; McKinney, K; Reed, C; Uva, R; Samuel, F; Roche-Manna, M; Standardi, C; Coyle, E; Boeckl, A; Pollack-Rundle, CJ; Carroll, CA; Sporn, A; Leone, A; Mowery, RL; Kassoff, A; Katz, LJ; Leef, D; Skuta, GL; Samuel, F; Lindblad, AS; Reed, C; Beckershoff, CC; Entler, G; Wagner, EL
      The Advanced Glaucoma Intervention Study, 8: Risk of cataract formation after trabeculectomy

      ARCHIVES OF OPHTHALMOLOGY
    16. Psaty, BM; Furberg, CD; Kuller, LH; Cushman, M; Savage, P; Levine, D; O'Leary, DH; Bryan, RN; Anderson, M; Lumley, T
      Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality - The cardiovascular health study

      ARCHIVES OF INTERNAL MEDICINE
    17. Heckbert, SR; Kaplan, RC; Weiss, NS; Psaty, BM; Lin, DY; Furberg, CD; Starr, JR; Anderson, GD; LaCroix, AZ
      Risk of recurrent coronary events in relation to use and recent initiationof postmenopausal hormone therapy

      ARCHIVES OF INTERNAL MEDICINE
    18. Klungel, OH; Heckbert, SR; Longstreth, WT; Furberg, CD; Kaplan, RC; Smith, NL; Lemaitre, RN; Leufkens, HGM; de Boer, A; Psaty, BM
      Antihypertensive drug therapies and the risk of ischemic stroke

      ARCHIVES OF INTERNAL MEDICINE
    19. Rautaharju, PM; Nelson, JC; Kronmal, RA; Zhang, ZM; Robbins, J; Gottdiener, JS; Furberg, CD; Manolio, T; Fried, L
      Usefulness of T-axis deviation as an independent risk indicator for incident cardiac events in older men and women free from coronary heart disease (The Cardiovascular Health Study)

      AMERICAN JOURNAL OF CARDIOLOGY
    20. Pocock, S; Furberg, CD
      Procedures of Data and Safety Monitoring Committees

      AMERICAN HEART JOURNAL
    21. Kaplan, RC; Heckbert, SR; Koepsell, TD; Furberg, CD; Polak, JF; Schoen, RE; Psaty, BM
      Risk factors for hospitalized gastrointestinal bleeding among older persons

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    22. Probstfield, JL; Applegate, WB; Berge, KE; Cutler, JA; Davis, B; Furberg, CD; Hawkins, CM; Pressel, S; Schron, EB; Smith, WM
      Systolic Hypertension in the Elderly Program (SHEP): The first demonstration that lowering systolic hypertension reduced total stroke and all coronary heart disease

      CLINICAL TRIALS IN HYPERTENSION
    23. Cutler, JA; Gordon, DJ; Davis, BR; Wright, JT; Furberg, CD
      Rationale and design for the antihypertensive and lipid-lowering treatmentto prevent heart attack trial (ALLHAT)

      CLINICAL TRIALS IN HYPERTENSION
    24. Crouse, JR; Furberg, CD
      Treatment of dyslipidemia - Room for improvement?

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    25. Psaty, BM; Furberg, CD
      Management of hypertension - Reply

      BRITISH MEDICAL JOURNAL
    26. Weber, MA; Furberg, CD
      Comparisons in a competitive world - When is one drug superior to another?

      AMERICAN JOURNAL OF HYPERTENSION
    27. Psaty, BM; Rhoads, C; Furberg, CD
      Evidence-based medicine - Worship of form and treatment of high blood pressure

      JOURNAL OF GENERAL INTERNAL MEDICINE
    28. Davis, B; Furberg, CD
      Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    29. Furberg, CD
      Class effects and evidence-based medicine

      CLINICAL CARDIOLOGY
    30. Pahor, M; Psaty, BM; Alderman, MH; Applegate, WB; Williamson, JD; Furberg, CD
      Therapeutic benefits of ACE inhibitors and other antihypertensive drugs inpatients with type 2 diabetes

      DIABETES CARE
    31. Pahor, M; Psaty, BM; Alderman, MH; Applegate, WB; Williamson, JD; Cavazzini, C; Furberg, CD
      Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials

      LANCET
    32. Furberg, CD; Psaty, BM; Herrington, DM
      Are drugs interchangeable? Reply

      LANCET
    33. Furberg, CD; Wright, JT; Davis, BR; Cutler, JA; Alderman, M; Black, H; Cushman, W; Grimm, R; Haywood, LJ; Leenen, F; Oparil, S; Perry, HM; Probstfield, J; Whelton, P; Payne, G; Nwachuku, C; Gordon, D; Proschan, M; Frommer, P; Einhorn, P; Hawkins, M; Ford, C; Pressel, S; Piller, L; Lusk, C; Bettencourt, J; Kimmel, B; Geraci, T; Walsh, S; Rahman, M; Juratovac, A; Pospisil, R; Brennan, K; Carroll, L; Sullivan, S; Barone, G; Christian, R; Feldman, S; Lucente, T; Lewis, CE; Jenkins, K; McDowell, P; Johnson, J; Kingry, C; Letterer, R; Margolis, K; Holland, L; Jaeger-Fox, B; Williamson, J; Louis, G; Ragusa, P; Williard, A; Ferguson, RS; Tanner, J; Eckfeldt, J; Crow, R; Pelosi, J
      Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT)

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    34. Herrington, DM; Reboussin, DM; Brosnihan, KB; Sharp, PC; Shumaker, SA; Snyder, TE; Furberg, CD; Kowalchuk, GJ; Stuckey, TD; Rogers, WJ; Givens, DH; Waters, D
      Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

      NEW ENGLAND JOURNAL OF MEDICINE
    35. Sacks, FM; Tonkin, AM; Shepherd, J; Braunwald, E; Cobbe, S; Hawkins, CM; Keech, A; Packard, C; Simes, J; Byington, R; Furberg, CD
      Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors - The prospective pravastatin pooling project

      CIRCULATION
    36. Ariyo, AA; Haan, M; Tangen, CM; Rutledge, JC; Cushman, M; Dobs, A; Furberg, CD
      Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans

      CIRCULATION
    37. Pitt, B; Byington, RP; Furberg, CD; Hunninghake, DB; Mancini, GBJ; Miller, ME; Riley, W
      Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events

      CIRCULATION
    38. Furberg, CD
      The nature of the statins - Response

      CIRCULATION
    39. Furberg, CD
      Natural statins and stroke - Response

      CIRCULATION
    40. Ederer, F; Sullivan, EK; Van Veldhuisen, PC; Gaasterland, DE; Wu, LL; Sonty, S; Beck, A; Schwartz, AL; Prum, BE; Costarides, A; Leef, D; Closek, J; Banks, J; Jackson, S; Moore, K; Vela, A; Brown, RH; Lynch, M; Gunsby, J; Lober, K; Marsh, T; Stepka, C; Montgomery, R; Clagett, D; Ashburn, F; Schacht, K; Coyle, E; Garland, MK; Lauber, S; Michelitsch, K; Plavnieks, S; Vayer, L; Burt, E; Hundley, M; Rae, A; Allen, RC; Miller, E; Sporn, A; Fendley, CK; Hoyle, LS; Weber, PA; McKinney, K; Moore, D; Lauderbaugh, T; Baker, ND; Kapetansky, F; Lehmann, D; Black, L; Derick, R; Gloeckner, B; Coleman, K; Cassady, M; Sharf, LJ; Romans, B; Satterwhite, Y; Simmons, L; Vela, MA; Harbin, TS; Brannon, L; Wright, J; LaSalle, J; Degenhardt, G; Bridgman, SA; Ozment, RR; Hooper, M; Goldstein, S; Butler, L; Perry, M; Eckel, A; Martin, A; Session, C; Nummerdor, D; Wille, L; Cyrlin, MN; Dubay, H; Fazio, R; Corbin, PS; Wilensky, JT; Lindenmuth, K; Hillman, D; Carroll, CA; Hatton, J; Carroll, CA; Higginbotham, EJ; Scholes, G; Uva, R; Fiene, J; Frohlichstein, D; Gates, V; Pappas, L; Rathbone, D; Tadelman, M; Hopkins, G; Lichter, PR; Bergstrom, TJ; Moroi, SE; Pollack-Rundle, CJ; Standardi, C; Abt, L; Van Heck, T; Skuta, GL; Higginbotham, EJ; Schertzer, RM; Wicker, D; Michael, B; Aaron, D; Birk, J; Brown, RS; Dederian, J; Kruscke, L; Ziehm-Scott, J; Papierniak-Dubiel, R; Prum, BE; Newman, SA; Powell, L; Evans, C; Barbour, N; Shoffstall-Tyler, L; Voight, T; Nordlund, JR; Schott, LJ; Fornili, R; Chisholm, J; Harrell, C; Harris, C; Murphy, E; Schwartz, AL; Weiss, H; Boeckl, A; Tillman, C; Boeckl, A; Maloney, L; Cirone, M; Gurley, J; Morris, M; O'Dea, M; Pappas, S; Wehrly, S; Reed, C; Witol, CV; Browning, J; Carmody, K; Driskell, T; Harris, E; Lopez, P; Mercer, R; Monks, V; Vawter, K; Zhao, J; Katz, LJ; Spaeth, GL; Wilson, RP; Myers, J; Samuel, F; Meli, A; Kao, S; Terebuh, A; Beckershoff, CC; Shields, MB; Shafranov, G; Leone, A; Grottole, G; Miller, E; Caprioli, J; Tressler, C; Roche-Manna, M; VanVeldhuisen, PC; Dally, LG; Blackwell, B; Inman, P; Raitt, S; Lindblad, AS; Knoke, JD; Sullivan, EK; Wu, LL; Entler, G; Phillips, P; Smith, C; Bradford, M; Denekas, M; Wagner, EL; Stine, E; Tomlin, KL; Voss, T; Cotch, MF; Darby, WW; Mowery, RL; Goff, F; Grimes, C; Lynch, G; Furberg, CD; Connett, JE; Daivs, MD; Dueker, DK; Green, SB; Palmberg, PF; Cotch, MF; Leikin, S; Schneiderman, M; Hamilton, MP; Mowery, RL; Schwartz, AL; Lindblad, AS; Knoke, JD; Sullivan, EK; Ederer, F; Schwartz, AL; Kassoff, A; Cotch, MF; Cyrlin, MN; Vela, MA; Caprioli, J; Higginbotham, EJ; Skuta, GL; Katz, LJ; Weber, PA; Allen, RC; Wilensky, JT; Miller, E; Brown, R; Prum, B; Cyrlin, M; Lichter, P; Leef, D; McKinney, K; Reed, C; Uva, R; Samuel, F; Manna, MR; Standardi, C; Coyle, E; Boeckl, A; Pollack-Rundle, CJ; Carroll, CA; Sporn, A; Leone, A; Mowery, RL; Kassoff, A; Katz, LJ; Leef, D; Skuta, GL; Standardi, C; Samuel, F; Lindblad, AS; Reed, C; Beckershoff, CC; Entler, G; Wagner, EL
      The advanced glaucoma intervention study, 6: Effect of cataract on visual field and visual acuity

      ARCHIVES OF OPHTHALMOLOGY
    41. Miller, M; Byington, R; Hunninghake, D; Pitt, B; Furberg, CD
      Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States andCanada

      ARCHIVES OF INTERNAL MEDICINE
    42. Psaty, BM; Furberg, CD; Pahor, M; Alderman, M; Kuller, LH
      National guidelines, clinical trials, and quality of evidence

      ARCHIVES OF INTERNAL MEDICINE
    43. Psaty, BM; Furberg, CD
      British guidelines on managing hypertension - Provide evidence, progress, and an occasional missed opportunity

      BRITISH MEDICAL JOURNAL
    44. Herrington, DR; Furberg, CD
      Hormone therapy: time for replacement?

      EUROPEAN HEART JOURNAL
    45. Furberg, CD; Herrington, DM; Psaty, BM
      Are drugs within a class interchangeable?

      LANCET
    46. Barzilay, JI; Spiekerman, CF; Wahl, PW; Kuller, LH; Cushman, M; Furberg, CD; Dobs, A; Polak, JF; Savage, PJ
      Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria

      LANCET
    47. Psaty, BM; Weiss, NS; Furberg, CD; Koepsell, TD; Siscovick, DS; Rosendaal, FR; Smith, NL; Heckbert, SR; Kaplan, RC; Lin, DY; Fleming, TR; Wagner, EH
      Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    48. Moore, TJ; Psaty, BM; Furberg, CD
      Time for action on drug safety - Reply

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    49. Sinzinger, H; Rodrigues, M; Furberg, CD
      Dosing of atorvastatin and increases in fibrinogen level

      ATHEROSCLEROSIS
    50. Furberg, CD
      Natural statins and stroke risk

      CIRCULATION
    51. Byington, RP; Evans, GW; Espeland, MA; Applegate, WB; Hunninghake, DB; Probstfield, J; Furberg, CD
      Effects of lovastatin and warfarin on early carotid atherosclerosis - Sex-specific analyses

      CIRCULATION
    52. Smith, NL; Psaty, BM; Furberg, CD; White, R; Lima, JAC; Newman, AB; Manolio, TA
      Temporal trends in the use of anticoagulants among older adults with atrial fibrillation

      ARCHIVES OF INTERNAL MEDICINE
    53. Psaty, BM; Furberg, CD; Kuller, LH; Bild, DE; Rautaharju, PM; Polak, JF; Bovill, E; Gottdiener, JS
      Traditional risk factors and subclinical disease measures as predictors offirst myocardial infarction in older adults - The cardiovascular health study

      ARCHIVES OF INTERNAL MEDICINE
    54. White, RH; McBurnie, MA; Manolio, T; Furberg, CD; Gardin, JM; Kittner, SJ; Bovill, E; Knepper, L
      Oral anticoagulation in patients with atrial fibrillation: Adherence with guidelines in an elderly cohort

      AMERICAN JOURNAL OF MEDICINE
    55. Furberg, CD
      Hypertension and diabetes: Current issues

      AMERICAN HEART JOURNAL
    56. Psaty, BM; Koepsell, TD; Lin, DY; Weiss, NS; Siscovick, DS; Rosendaal, FR; Pahor, M; Furberg, CD
      Assessment and control for confounding by indication in observational studies

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    57. PAHOR M; FURBERG CD
      IS THE USE OF SOME CALCIUM-ANTAGONISTS LINKED TO CANCER - EVIDENCE FROM RECENT OBSERVATIONAL STUDIES

      Drugs & aging
    58. Pahor, M; Furberg, CD
      Calcium antagonists and cancer: Causation or association?

      CARDIOVASCULAR DRUGS AND THERAPY
    59. PEARCE KA; FURBERG CD; PSATY BM; KIRK J
      COST-MINIMIZATION AND THE NUMBER NEEDED TO TREAT IN UNCOMPLICATED HYPERTENSION

      American journal of hypertension
    60. MILLER M; BYINGTON RP; HUNNINGHAKE D; FURBERG CD; PITT B
      LIPID-LOWERING THERAPY IN CAD PATIENTS AT ACADEMIC MEDICAL-CENTERS - UNDERTREATMENT AND EVIDENCE OF A GENDER-GAP

      Journal of the American College of Cardiology
    61. FURBERG CD
      OVERVIEW OF HYPERTENSION TRIALS

      Zhongguo yaoli xuebao
    62. PAHOR M; PSATY BM; FURBERG CD
      NEW EVIDENCE ON THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES

      Journal of cardiovascular pharmacology
    63. BYINGTON RP; FURBERG CD; CRAVEN TE; PAHOR M; SOWERS JR
      ISRADIPINE IN PREDIABETIC HYPERTENSIVE SUBJECTS

      Diabetes care
    64. PAHOR M; PSATY BM; FURBERG CD
      CALCIUM-CHANNEL BLOCKERS AND CARDIOVASCULAR RISK IN DIABETES - REPLY

      Lancet
    65. PAHOR M; PSATY BM; FURBERG CD
      TREATMENT OF HYPERTENSIVE PATIENTS WITH DIABETES

      Lancet
    66. FURBERG CD; PSATY BM
      JNC VI GUIDELINES - REPLY

      Lancet
    67. MOORE TJ; PSATY BM; FURBERG CD
      TIME TO ACT ON DRUG SAFETY

      JAMA, the journal of the American Medical Association
    68. CROUSE JR; BYINGTON RP; FURBERG CD
      HMG-COA REDUCTASE INHIBITOR THERAPY AND STROKE RISK REDUCTION - AN ANALYSIS OF CLINICAL-TRIALS DATA (VOL 138, PG 11, 1998)

      Atherosclerosis (Amsterdam)
    69. CROUSE JR; BYINGTON RP; FURBERG CD
      HMG-COA REDUCTASE INHIBITOR THERAPY AND STROKE RISK REDUCTION - AN ANALYSIS OF CLINICAL-TRIALS DATA

      Atherosclerosis
    70. MARSHALL RJ; GOTTDIENER JS; SHEMANSKI L; FURBERG CD; CUSHMAN M; POLAK JF; SMITH V; GERSH BJ
      INFLUENCE OF LV FUNCTION ON MORTALITY IN ELDERLY WITH CONGESTIVE-HEART-FAILURE - THE CARDIOVASCULAR HEALTH STUDY

      Circulation
    71. GOULD AL; ROSSOUW JE; SANTANELLO NC; HEYSE JF; FURBERG CD
      CHOLESTEROL REDUCTION YIELDS CLINICAL BENEFIT - IMPACT OF STATIN TRIALS

      Circulation
    72. LEMAITRE RN; FURBERG CD; NEWMAN AB; HULLEY SB; GORDON DJ; GOTTDIENER JS; MCDONALD RH; PSATY BM
      TIME TRENDS IN THE USE OF CHOLESTEROL-LOWERING AGENTS IN OLDER ADULTS- THE CARDIOVASCULAR HEALTH STUDY

      Archives of internal medicine
    73. CROUSE JR; BYINGTON RP; HOEN HM; FURBERG CD
      LOWERING OF CHOLESTEROL LEVELS AND THE RISK OF STROKE - REPLY

      Archives of internal medicine
    74. HECKBERT SR; FURBERG CD; LONGSTRETH WT; PSATY BM; SMITH NL
      ANTIHYPERTENSIVE MEDICATIONS - IN REPLY

      Journal of the American Geriatrics Society
    75. PAHOR M; PSATY BM; FURBERG CD
      EDITORIAL DEBATE

      JN. Journal of nephrology
    76. MANOLIO TA; WEINMANN GG; BUIST AS; FURBERG CD; PINSKY JL; HURD SH
      PULMONARY-FUNCTION TESTING IN POPULATION-BASED STUDIES

      American journal of respiratory and critical care medicine
    77. PSATY BM; FURBERG CD
      CLINICAL IMPLICATIONS OF THE WORLD-HEALTH-ORGANIZATION INTERNATIONAL-SOCIETY-OF-HYPERTENSION STATEMENT ON CALCIUM-ANTAGONISTS

      Journal of hypertension
    78. FURBERG CD; PSATY BM
      JNC-VI - TIMING IS EVERYTHING

      Lancet
    79. BYINGTON RP; CRAVEN TE; FURBERG CD; PAHOR M
      ISRADIPINE, RAISED GLYCOSYLATED HEMOGLOBIN, AND RISK OF CARDIOVASCULAR EVENTS

      Lancet
    80. PSATY BM; SMITH NL; SISCOVICK DS; KOEPSELL TD; WEISS NS; HECKBERT SR; LEMAITRE RN; WAGNER EH; FURBERG CD
      HEALTH OUTCOMES ASSOCIATED WITH ANTIHYPERTENSIVE THERAPIES USED AS FIRST-LINE AGENTS - A SYSTEMATIC REVIEW AND METAANALYSIS

      JAMA, the journal of the American Medical Association
    81. PAUL O; ARNOLD CB; MANDRIOTA R; AMES RP; EISENBACH JR; BOHN E; THOMAS HE; KANNEL WB; ROTONDO R; CONNORS J; BRAND FN; SMITH LK; PRISCO MT; GREENE P; KEZDI P; STANLEY EL; BLACK WL; ERNST FA; CASE EJ; BENTLEY V; COVERT D; LUCIUS M; PARIS F; SEMMETT R; SKOTKO L; CHRISTAKIS G; BURR JM; GERACE TA; WILCOX ME; BRAMSON D; BENEZRA J; WEDDLE J; KAYE J; PADRON M; RAUTAHARJU PM; WOLF H; BENFARI RC; MCINTYRE KM; DANIELSON E; OCKENE J; KOUSCHHOWARD D; BALDWIN AD; WILD JB; GREENLICK M; GROVER J; LAMB S; BAILEY J; DYER J; BROKOP B; STEVENS V; BAILEY G; HOLMES W; PICKERING JE; ALLAIRE J; DUFFY EL; FELLON D; FEINSTEIN B; HUTCHINS D; RUBEL G; COOPER GR; BAYSE DD; MILLER DT; HAINLINE A; KUCHMAK M; WIEBE DA; WINN CL; TAYLOR L; BOTERO BL; GILL JB; LASSER NL; HYMOWITZ N; MEZEY KC; MUNVES B; PARELL E; BURGIO S; LASSER V; JOHNSON B; JEFFREY S; RICE E; STAMLER J; MOSS D; PERSKY V; ROBINSON E; VANHORN L; SHANNON K; MEYERS D; COHEN L; MORGAN J; GRUNDMANN G; VESTAL TD; HUANG B; BERKSON DM; LAUGER G; GRUJIC S; OBRADOVIC D; PARDO E; DUA S; MCGOWAN S; BILLINGS J; HULLEY SB; SMITH WM; SYME SL; COHEN R; DZVONIK L; ROOS L; KAHN M; WIDDOWSON GM; WILLIAMS GZ; KUEHNEMAN ML; SCHOENBERGER JA; SCHOENENBERGER JC; SHEKELLE RB; NERI GS; DOLECEK T; BETZ E; SKWERES L; OPPENHEIMER F; GERNHOFER N; HARDY GG; MCGILL E; HALL Y; WRIGHT NH; KOPEL SA; SUCKERMAN KR; SCHORIN M; SIMON N; COHEN JD; BUNKERS E; RONCHETTO B; GRODSKY E; FRESSOLA A; DANIELGENTRY J; TREIMAN R; SULLIVAN W; SCHNAPER HW; HUGHES GH; OBERMAN A; HILL CC; ALLEN R; BRAGG C; STOKES S; JOHNSON P; BORHANI NO; SUGARS C; KIRKPATRICK K; LEE M; DEBOURELANDO S; LABAW F; TURNERTUCKER J; SHERWIN RW; SEXTON MS; CUSACK NE; DEBARROS QTF; DISCHINGER PC; SPIZLER JF; HEINER JD; PILKINGTON MB; SCANLON BL; GRIMM RH; MITTELMARK M; CROW RS; BLACKBURN H; JACOBS D; RAINS D; MCDONALD M; LENZ K; PRINEAS RJ; CROW RC; BUZZARD IM; GRAMBSCH PV; WENZ J; KJELSBERG MO; BARTSCH GE; NEATON JD; AUS BM; BENDICKSON J; BROSTE SK; CONNETT JE; DUCHENE AG; DURKIN DA; GORDER DL; GRANDITS GA; HULTGREN DH; KNICKERBOCKER A; RASMUSSEN WL; SVENDSEN KH; WILLE L; KULLER LH; MCDONALD R; CAGGIULA A; FALVOGERARD L; MEILAHN E; MILAS NC; RUSSELL R; HORBIAK J; ALMAN M; SOUTHWICK K; MOYER R; GAHAGAN E; GIESE WK; MARTIN JF; KEITH JA; HARRISON HH; MATHIS DE; BROWN CK; FISHMAN E; WAMPLER L; NEWMARK G; ROSENFIELD F; SIDDIQUI S; SAVAGE W; BRADFORD A; INSULL W; FARQUHAR JW; JENKINS CD; RAPAPORT E; THOMPSON DJ; TYROLER HA; WILLIS PW; FRIEDEWALD WT; ZUKEL W; DOYLE JT; BURCHELL HB; YU PN; WILLIS PW; FURBERG CD; CUTLER JA; ZUKEL WJ; PASSAMANI ER; KAELBER CT; FARRAND ME; TILLOTSON JL; VERTER JI; WU MC; GORDON T; HALPERIN M; MCGEE DL; BLASZKOWSKI TP; EBERLEIN KA; HARRIS CE; DERN PL; FRIEDMAN LM; MAY GS; VARGOSKO AJ
      MULTIPLE RISK FACTOR INTERVENTION TRIAL - RISK FACTOR CHANGES AND MORTALITY RESULTS (REPRINTED FROM JAMA, VOL 248, PG 1465-1477, 1982)

      JAMA, the journal of the American Medical Association
    82. APPLEGATE WB; FURBERG CD; BYINGTON RP; GRIMM R
      THE TICENTER-ISRADIPINE-DIURETIC-ATHEROSCLEROSIS-STUDY (MIDAS)

      JAMA, the journal of the American Medical Association
    83. PSATY BM; SMITH NL; KOEPSELL TD; FURBERG CD
      PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE END-POINTS USING BETA-BLOCKERS - REPLY

      JAMA, the journal of the American Medical Association
    84. LEGAULT C; FURBERG CD; WAGENKNECHT LE; TROOST BT; COKER LH; ROGERS AT; STUMP DA
      IS NIMODIPINE IN CARDIAC-SURGERY REALLY SO BAD - RESPONSE

      Stroke
    85. PSATY BM; MANOLIO TA; KULLER LH; KRONMAL RA; CUSHMAN M; FRIED LP; WHITE R; FURBERG CD; RAUTAHARJU PM
      INCIDENCE OF AND RISK-FACTORS FOR ATRIAL-FIBRILLATION IN OLDER ADULTS

      Circulation
    86. SOBEL BE; FURBERG CD
      SURROGATES, SEMANTICS, AND SENSIBLE PUBLIC-POLICY

      Circulation
    87. FURBERG CD
      NEW DEVELOPMENTS IN THE CALCIUM-CHANNEL ANTAGONIST CONTROVERSY - RESPONSE

      Circulation
    88. FURBERG CD; PSATY BM
      NIFEDIPINE TRIALS - RESPONSE

      Circulation
    89. FITZPATRICK AL; DALING JR; FURBERG CD; KRONMAL RA; WEISSFELD JL
      USE OF CALCIUM-CHANNEL BLOCKERS AND BREAST-CARCINOMA RISK IN POSTMENOPAUSAL WOMEN

      Cancer
    90. CROUSE JR; BYINGTON RP; HOEN HM; FURBERG CD
      REDUCTASE INHIBITOR MONOTHERAPY AND STROKE PREVENTION

      Archives of internal medicine
    91. BYINGTON RP; MILLER ME; HERRINGTON D; RILEY W; PITT B; FURBERG CD; HUNNINGHAKE DB; MANCINI GBJ
      RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE RANDOMIZED EVALUATION OF THE VASCULAR EFFECTS OF NORVASC TRIAL (PREVENT)

      The American journal of cardiology
    92. HECKBERT SR; LONGSTRETH WT; PSATY BM; MURROS KE; SMITH NL; NEWMAN AB; WILLIAMSON JD; BERNICK C; FURBERG CD
      THE ASSOCIATION OF ANTIHYPERTENSIVE AGENTS WITH MRI WHITE-MATTER FINDINGS AND WITH MODIFIED MINI-MENTAL-STATE-EXAMINATION IN OLDER ADULTS

      Journal of the American Geriatrics Society
    93. PAHOR M; PSATY BM; FURBERG CD
      CALCIUM-CHANNEL BLOCKERS - WHAT IS THEIR ROLE IN THE TREATMENT OF HYPERTENSION IN RENAL PATIENTS

      JN. Journal of nephrology
    94. FURBERG CD; PSATY BM
      SHOULD CALCIUM-ANTAGONISTS BE FIRST-LINE AGENTS IN THE TREATMENT OF CARDIOVASCULAR-DISEASE - THE PUBLIC-HEALTH PERSPECTIVE

      Cardiovascular drugs and therapy
    95. DAVIS BR; CUTLER JA; GORDON DJ; FURBERG CD; WRIGHT JT; CUSHMAN WC; GRIMM RH; LAROSA J; WHELTON PK; PERRY HM; ALDERMAN MH; FORD CE; OPARIL S; FRANCIS C; PROSCHAN M; PRESSEL S; BLACK HR; HAWKINS CM
      RATIONALE AND DESIGN FOR THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT)

      American journal of hypertension
    96. FURBERG CD; PSATY BM
      CALCIUM-ANTAGONISTS - NOT APPROPRIATE AS FIRST LINE ANTIHYPERTENSIVE AGENTS

      American journal of hypertension
    97. PSATY BM; SISCOVICK DS; WEISS NS; KOEPSELL TD; ROSENDAAL FR; LIN DY; HECKBERT SR; WAGNER EH; FURBERG CD
      HYPERTENSION AND OUTCOMES RESEARCH - FROM CLINICAL-TRIALS TO CLINICALEPIDEMIOLOGY

      American journal of hypertension
    98. FURBERG CD; HENNEKENS CH; HULLEY SB; MANOLIO T; PSATY BM; WHELTON PK
      TASK-FORCE 2 - CLINICAL EPIDEMIOLOGY - THE CONCEPTUAL BASIS FOR INTERPRETING RISK-FACTORS

      Journal of the American College of Cardiology
    99. RILEY WA; CRAVEN T; ROMONT A; FURBERG CD
      ASSESSMENT OF TEMPORAL BIAS IN LONGITUDINAL MEASUREMENTS OF CAROTID INTIMAL-MEDIAL THICKNESS IN THE ASYMPTOMATIC CAROTID-ARTERY PROGRESSIONSTUDY (ACAPS)

      Ultrasound in medicine & biology
    100. FURBERG CD; PAHOR M; PSATY BM
      THE UNNECESSARY CONTROVERSY

      European heart journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 00:44:52